Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
77 participants
OBSERVATIONAL
2020-07-01
2021-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immediate Effects of Open and Closed Kinetic Chain Exercises on Upper Extremity in Stroke Patients.
NCT06272175
Spinal Straightness, Posture And Balance, Physical Performance And Energy Consumption In Individuals With Stroke
NCT06699381
The Efficiency of Video-Based Exercises in Individuals With Stroke
NCT05251571
Talocrural Joint Manipulation in Stroke
NCT06523010
Relation of Functional ındependence to Balance, Exercise Capacity, and Peripheral Muscle Strength
NCT05665673
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study, which is designed as a prospective observational study, patients with subacute stroke who have a stroke for the first time and are admitted to the hospital for the first rehabilitation treatment and healthy volunteers (control group) will be included. The clinical conditions of the patients will be evaluated at the beginning and after the 4-week rehabilitation program at the time of discharge by National Institutes of Health Stroke Scale Scores (NIHSS), modified Rankin Scale (mRS) and Barthel Daily Living Activities Index (BI). Serum and whole blood samples will be obtained from the patient group at the beginning and at discharge, and from the control group. The SH-SS homeostasis parameters (SH, Total SH, SS and SS / SH percent ratio) from serum samples and GSSG-GSH homeostasis parameters (GSH, Total GSH, GSSG and GSSG / GSH percentage ratio) from whole blood samples will be determined. Age, gender, hemiplegic side, type of stroke will be noted. Later, statistical analysis will be conducted.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
post-stroke patient
patients with subacute stroke who have a stroke for the first time and admitted to the hospital for the first rehabilitation treatments
Standard neurorehabilitation
Routine post-stroke rehabilitation
Thiol-Disulphide Homeostasis
Monitoring the levels of thiol and disulphide in serum
Oxidized-reduced Glutathione Homeostasis
Monitoring the levels of intracellular oxidized glutathione and reduced glutathione in whole blood samples
Control
healthy volunteers who have not got any known disease and any sign in physical examination
Thiol-Disulphide Homeostasis
Monitoring the levels of thiol and disulphide in serum
Oxidized-reduced Glutathione Homeostasis
Monitoring the levels of intracellular oxidized glutathione and reduced glutathione in whole blood samples
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard neurorehabilitation
Routine post-stroke rehabilitation
Thiol-Disulphide Homeostasis
Monitoring the levels of thiol and disulphide in serum
Oxidized-reduced Glutathione Homeostasis
Monitoring the levels of intracellular oxidized glutathione and reduced glutathione in whole blood samples
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted to the hospital for standard neurorehabilitation within 1 to 6 months of stroke onset
* healthy individuals (for control group)
Exclusion Criteria
* significant acute neurological illness other than stroke (e.g., head trauma, brain abscess, brain tumor, migraine attack, seizure)
* cannot adapt to work
* previous history of neurorehabilitation therapy
* taking the antioxidant supplements
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abant Izzet Baysal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tugba Alisik, MD
Role: PRINCIPAL_INVESTIGATOR
Abant Izzet Baysal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bolu Abant Izzet Baysal University
Bolu, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 Jul;20(7):864-70. doi: 10.1161/01.str.20.7.864.
Kucukdeveci AA, Yavuzer G, Tennant A, Suldur N, Sonel B, Arasil T. Adaptation of the modified Barthel Index for use in physical medicine and rehabilitation in Turkey. Scand J Rehabil Med. 2000 Jun;32(2):87-92.
Broderick JP, Adeoye O, Elm J. Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. Stroke. 2017 Jul;48(7):2007-2012. doi: 10.1161/STROKEAHA.117.017866. Epub 2017 Jun 16. No abstract available.
Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014 Dec;47(18):326-32. doi: 10.1016/j.clinbiochem.2014.09.026. Epub 2014 Oct 7.
Alisik, M., Neselioglu, S., & Erel, O. (2019). A colorimetric method to measure oxidized, reduced and total glutathione levels in erythrocytes, Journal of Laboratory Medicine, 43(5), 269-277
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AIBU-FTR-TA-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.